ClinicalTrials.Veeva

Menu

Ultrasound and Clinical Approach for the Dynamic Assessment of Fluid Tolerance in the Intensive Care Unit (FLUID-REACT)

U

University Hospital Center (CHU) Dijon Bourgogne

Status

Enrolling

Conditions

Volume Expander

Treatments

Procedure: Cardiac ultrasound
Procedure: Lung ultrasound

Study type

Observational

Funder types

Other

Identifiers

NCT06415916
GUINOT 2024

Details and patient eligibility

About

A major cause of admission to intensive care is acute circulatory failure resulting from organ hypoperfusion due to factors such as hypotension and myocardial dysfunction. The standard treatment, including volume expansion and vasopressor/inotropic agents, often leads to water and sodium overload, increasing the risk of morbidity and mortality in the ICU. The combination of this overload and myocardial dysfunction lead to venous congestion, particularly affecting the lungs, kidneys and gastrointestinal system. Effective fluid management is therefore crucial to maintain a balance between adequate tissue perfusion and prevention of fluid overload. Fluid tolerance, defined as a patient's ability to tolerate additional volumes of solutes without adverse effects, is assessed retrospectively by clinical signs (capillary refill time, oedema, hepatojugular reflux, etc.) and ultrasound scores (VExUS score, LUS score, etc.). However, these indicators do not fully reflect the complexity of venous congestion in patients with various conditions.

Assessing fluid tolerance remains a challenge in clinical practice. It requires a personalised approach and the use of dynamic tests such as passive leg raising to predict response to vascular filling. Despite their common use, there are no studies evaluating the ability of changes in congestion markers during passive leg raising to predict fluid tolerance.

In conclusion, the main hypothesis is that changes in ultrasound congestion parameters (VExUS score, LUS score and others) during passive leg raising could predict a patient's subsequent tolerance to volume expander.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patient
  • Patient who has provided non-opposition (or health proxy or a close relative if unable to receive the information)
  • Patient admitted to intensive care and requiring volume expander

Exclusion criteria

  • Person subject to a legal protection measure (curatorship, guardianship)
  • Person subject to a legal protection measure
  • Pregnant, parturient or breast-feeding women
  • Poor echogenicity assessed by the operator
  • Chronic AC/FA
  • Mechanical cardiac assistance

Trial design

100 participants in 1 patient group

patient
Description:
Patients admitted to intensive care who require volume expander
Treatment:
Procedure: Lung ultrasound
Procedure: Cardiac ultrasound

Trial contacts and locations

1

Loading...

Central trial contact

Pierre-Grégoire GUINOT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems